Montgomery Buprenorphine Doctors

 

Feature Your Practice at the Top of This City Page

Locate Montgomery buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.

Richard Alan Stehl, MD
P O Box 242522
Montgomery, AL 36124
Main Tel: 334-558-0908
 
 
Dr. Scott Alexander Bell, M.D.
138 Adams Ave. Suite 3
Montgomery, AL 36104
Main Tel: (334) 328-5574
 
 
Dr. Joseph Patrick Lucas, M.D.
4371 Narrow Lane Road
Montgomery, AL 36116
Main Tel: (334) 323-3307
 
 
Dr. Clemmie Lee Palmer, III, M.D.
3090 Woodley Road
Montgomery, AL 36116
Main Tel: (334) 280-3230
 
 
Dr. Gilberto Sanchez, M.D.
4143 Atlanta Highway
Montgomery, AL 36109
Main Tel: (334) 271-4503
 
 
DLivro L. Beauchamp, M.D.
4705 Woodmere Boulevard
Montgomery, AL 36106
Main Tel: (334) 558-0262
 
 
Dr. Gregory Philip Jones, D.O.
470 Taylor Road
Suite 300
Montgomery, AL 36117
Main Tel: (334) 281-1191
 
 
Dr. Shankar B. Yalamanchili, M.D.
233 Winton M Blount Loop
Montgomery, AL 36117
Main Tel: (334) 270-5502
 
 
Dr. Anil Pal Saini,
233 Winton M. Blount Loop
Montgomery, AL 36117
Main Tel: (334) 270-5502
 
 
Dr. Ramakanth K. Vemuluri,
7085 Sydney Curve
Montgomery, AL 36117
Main Tel: (334) 270-5502
 
 

Sublocade Now Available

Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More

Posted in Buprenorphine, Medication-Assisted Treatment | Tagged | Leave a comment

Ohio Increases Buprenorphine Access

In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More

Posted in Addiction Medications, Buprenorphine, Medication-Assisted Treatment, Suboxone | Tagged , | Leave a comment

The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.

Buprenorphine is the medication ingredient in Suboxone, Subutex, Zubsolv, Bunavail, and Probuphine that specifically targets opioid withdrawal. Buprenorphine, or "Bup", is the leading pharmaceutical treatment (alongside methadone) for addressing opioid addiction. Both medications are in widescale use throughout the world due to their efficacy in removing the persistent discomfort associated with withdrawal from opiates (ex. runny nose, body ache, anxiety, nausea, diarrhea and other symptoms).

Buprenorphine.US is an information resource for people in search of doctors who specialize in treating opioid addiction with buprenorphine. In recent years, individuals from all age groups and backgrounds have suffered with an unexpected opioid dependency that negatively affected their family relationships, job, finances, and self-esteem. Addiction is a relentless illness, and persistent opiate withdrawal is a particularly difficult medical dilemma. There are presently thousands of U.S. physicians seeking to assist patients ready to address their opioid addiction. Buprenorphine.US is a tool for connecting buprenorphine doctors with new prospective patients wanting specialized primary care for their addictive disorder.